β整合素家族在儿童急性T淋巴细胞白血病的表达及其临床意义

孔庆琳, 安曦洲, 管贤敏, 马义梅, 李朋飞, 梁绍燕, 胡艳妮, 崔颖慧, 于洁

中国当代儿科杂志 ›› 2017, Vol. 19 ›› Issue (6) : 620-626.

PDF(1505 KB)
HTML
PDF(1505 KB)
HTML
中国当代儿科杂志 ›› 2017, Vol. 19 ›› Issue (6) : 620-626. DOI: 10.7499/j.issn.1008-8830.2017.06.003
论著·临床研究

β整合素家族在儿童急性T淋巴细胞白血病的表达及其临床意义

  • 孔庆琳, 安曦洲, 管贤敏, 马义梅, 李朋飞, 梁绍燕, 胡艳妮, 崔颖慧, 于洁
作者信息 +

Expression of β-integrin family members in children with T-cell acute lymphoblastic leukemia

  • KONG Qing-Lin, AN Xi-Zhou, GUAN Xian-Min, MA Yi-Mei, LI Peng-Fei, LIANG Shao-Yan, HU Yan-Ni, CUI Ying-Hui, YU Jie
Author information +
文章历史 +

摘要

目的 探讨β整合素家族成员在儿童急性T淋巴细胞白血病(T-ALL)的表达及临床意义。方法 收集22例初诊T-ALL患儿和21例对照(非恶性血液病患者和骨髓移植供者)的骨髓标本,采用实时荧光定量PCR方法,检测β整合素家族各成员的mRNA表达;并利用整合素抑制剂精氨酸-甘氨酸-天冬氨酸(RGD)肽作用于Jurkat细胞,采用CCK 8法和流式细胞术检测Jurkat细胞生存率和凋亡情况。结果 与对照组相比,T-ALL患儿的整合素β2、β3、β5的mRNA表达水平显著下调(P < 0.05)。在外周血白细胞计数< 100×109/L、第33天骨髓不缓解或MRD阳性的T-ALL患儿中,整合素β3表达水平较高(P < 0.05);复发T-ALL患儿整合素β5的表达高于无复发T-ALL患儿(P < 0.05)。整合素β3高表达T-ALL患儿的EFS率、OS率均低于β3低表达者(P < 0.05)。与未处理组比较,RGD肽处理的Jurkat细胞生存率较低、凋亡率均高(P < 0.05)。结论 β整合素可能通过影响细胞的增殖和凋亡而影响T-ALL的发生发展,整合素β5的表达与T-ALL复发风险密切相关,整合素β3的表达与T-ALL患儿治疗反应及预后密切相关。

Abstract

Objective To study the expression of β-integrin family members in children with T-cell acute lymphoblastic leukemia (T-ALL) and their significance. Methods Quantitative real-time PCR analyses were performed to assess the expression levels of β-integrin family members in bone marrow samples from 22 children with newly-diagnosed T-ALL and 21 controls (16 children with non-malignant hematologic disease and 5 healthy donors with bone marrow transplantation). Jurkat cells were treated with integrin inhibitor arginine-glycine-aspartate (Arg-Gly-Asp, RGD) peptide. The cell viability and apoptosis rate were determined by CCK8 assay and flow cytometry respectively. Results The mRNA levels of integrins β2, β3, and β5 were significantly lower in children with T-ALL than in controls (P < 0.05). In T-ALL patients, high integrin β3 expression was associated with lower white blood cell counts (< 100×109/L), minimal residual disease (MRD) positivity, and day 33 bone marrow negative remission (P < 0.05). In T-ALL patients, higher integrin β5 expression was associated with relapse of T-ALL (P < 0.05). Based on survival curve analysis, higher integrin β3 expression was related to lower event-free survival and overall survival rates. RGD peptide treatment inhibited the proliferation of Jurkat cells and increased their apoptosis rate (P < 0.05). Conclusions β-Integrin may play a role in the occurrence and development of T-ALL by affecting cell proliferation and apoptosis. The expression of integrin β5 is closely related to the risk of relapse of T-ALL. The expression of integrin β3 is closely related the treatment response and prognosis of T-ALL.

关键词

急性T淋巴细胞白血病 / β整合素 / 生存分析 / RGD肽 / Jurkat细胞 / 儿童

Key words

T-cell acute lymphoblastic leukemia / β-Integrin / Survival analysis / Arginine-glycine-aspartate / Jurkat cell / Child

引用本文

导出引用
孔庆琳, 安曦洲, 管贤敏, 马义梅, 李朋飞, 梁绍燕, 胡艳妮, 崔颖慧, 于洁. β整合素家族在儿童急性T淋巴细胞白血病的表达及其临床意义[J]. 中国当代儿科杂志. 2017, 19(6): 620-626 https://doi.org/10.7499/j.issn.1008-8830.2017.06.003
KONG Qing-Lin, AN Xi-Zhou, GUAN Xian-Min, MA Yi-Mei, LI Peng-Fei, LIANG Shao-Yan, HU Yan-Ni, CUI Ying-Hui, YU Jie. Expression of β-integrin family members in children with T-cell acute lymphoblastic leukemia[J]. Chinese Journal of Contemporary Pediatrics. 2017, 19(6): 620-626 https://doi.org/10.7499/j.issn.1008-8830.2017.06.003

参考文献

[1] Durinck K, Goossens S, Peirs S, et al. Novel biological insights in T-cell acute lymphoblastic leukemia[J]. Exp Haematol, 2015, 43(8):625-639.
[2] Cox CV, Martin HM, Keams PR, et al. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia[J]. Blood, 2007, 109(2):674-682.
[3] Goldberg JM, Silverman LB, Levy DE, et al. Childhood T-cell acute lymphoblastic leukemia:the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience[J]. J Clin Oncol, 2003, 21(19):3616-3622.
[4] Desgrosellier JS, Cheresh DA. Integrins in cancer:biological implications and therapeutic opportunities[J]. Nat Rev Cancer, 2010, 10(1):9-22.
[5] Hynes RO. Integrins:bidirectional, allosteric signaling machines[J]. Cell, 2002, 110(6):673-687.
[6] Kapp TG, Rechenmacher F, Sobahi TR, et al. Integrin modulators:a patent review[J]. Expert Opin Ther Pat, 2013, 23(10):1273-1295.
[7] Lambert AW, Ozturk S, Thiagalingam S. Integrin signaling in mammary epithelial cells and breast cancer[J]. ISRN Oncol, 2012, 2012:493283.
[8] Akkari L, Gocheva V, Kester JC, et al. Distinct functions of macrophage-derived and cancer cell-derived cathepsin Z combine to promote tumor malignancy via interactions with the extracellular matrix[J]. Genes Dev, 2014, 28(19):2134-2150.
[9] 中华医学会儿科学分会血液组, 中华儿科杂志编辑委员会. 儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J]. 中华儿科杂志, 2006, 44(5):392-395.
[10] 孙伊娜, 柴忆欢, 何海龙, 等. CCLG-ALL2008方案治疗儿童急性淋巴细胞性白血病的临床疗效[J]. 江苏医药, 2011, 24(37):2922-2925.
[11] 秘营昌, 卞寿庚. 急性白血病[M]//张之南, 沈悌. 血液病诊断及疗效标准. 第3版. 北京:科学出版社, 2007:131-134.
[12] Kapp TG, Rechenmacher F, Sobahi TR, et al. Integrin modulators:a patent review[J]. Expert Opin Ther Pat, 2013, 23(10):1273-1295.
[13] Roth P, Silginer M, Goodman SL, et al. Integrin control of the transforming growth factor-β pathway in glioblastoma[J]. Brain, 2013, 136(Pt 2):564-576.
[14] 王耀平. 儿童及少年急性淋巴细胞白血病危险因素评估[J]. 白血病.淋巴瘤, 2005, 14(4):241-242.
[15] 王跃平. 儿童急性白血病诊治进展[J]. 实用医院临床杂志, 2007, 4(6):33-38.
[16] Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia[J]. Lancet, 2008, 371(9617):1030-1043.
[17] 管箫玉, 李庆伟, 王继红. RGD肽抗肿瘤机制及进展[J].吉林医药学院学报, 2015, 36(5):361-365.
[18] 沈瑛, 糜军. 靶向整合素αVβ3的分子影像探针[J].中国癌症杂志, 2010, 20(4):303-307.

基金

重庆市卫生局课题(2015MSXM031)。


PDF(1505 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/